Lapatinib and capecitabine as third-line therapy in young woman with advanced breast cancer

We report the case of a young woman with HER2-positive advanced breast cancer, arising during pregnancy, with visceral involvement at onset, treated with third line therapy with the combination lapatinib and capecitabine resulting in a nearly complete long-term tumor response . The patient had prev...

Full description

Bibliographic Details
Main Author: Michela Donadio
Format: Article
Language:English
Published: AboutScience Srl 2018-06-01
Series:AboutOpen
Subjects:
Online Access:https://journals.aboutscience.eu/index.php/aboutopen/article/view/55

Similar Items